{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Noblesville",
      "state": "IN",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68191",
      "recalling_firm": "Pharmakon Pharmaceuticals",
      "address_1": "14450 Getz Rd",
      "address_2": "N/A",
      "postal_code": "46060-3303",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "United States: TX, IL, MD, IN",
      "recall_number": "D-1568-2014",
      "product_description": "Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only.  Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN.  NDC: 45183-0105-78.",
      "product_quantity": "5 Syringes",
      "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.",
      "recall_initiation_date": "20140421",
      "center_classification_date": "20140826",
      "termination_date": "20141203",
      "report_date": "20140903",
      "code_info": "Lot #: E0333282R; Exp: 7/13/2014"
    }
  ]
}